At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function:
Market AccessJob Sub Function:
Health Economics Market AccessJob Category:
ProfessionalAll Job Posting Locations:
Beerse, Antwerp, Belgium, Raritan, New Jersey, United States of AmericaJob Description:
About Innovative Medicine
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
Johnson & Johnson Innovative Medicine (JJIM) is currently recruiting for a Director, Health Technology Assessment & Decision Science (HTA & DS), within the Global Commercial Strategy Organization (GCSO), to be located in Raritan, NJ or Beerse, Belgium.
The Director, Health Technology Assessment & Decision Science (HTA & DS) plays a critical role in informing and shaping internal decision making on our clinical development programs, complementary evidence generation and market access strategies across the J&J Innovative Medicine portfolio, supporting timely global market access, reimbursement and coverage.
The role sits within the Global Commercial Strategy Organization’s Market Access Center of Excellence and partners closely with Therapy Area and Regional Market Access, R&D, Regulatory, and other cross‑functional teams worldwide.
Key Responsibilities
- Inform and support internal decision making at internal stage gate, governance meetings and functional advisory meetings by
- translating HTA agency, payer and health system insights and benchmarks for key markets (incl. US, Japan, EU G4, UK) into actionable decision‑science inputs for development programs and access & evidence generation strategies. Leverage generative AI to enable and enhance internal decision making.
- leading, supporting and delivering early HTA agency advice activities, including individual agency and multi-agency procedures (e.g. EU Joint Scientific Consultations) across the portfolio, in collaboration with product teams.
- EU Joint Clinical Assessments strategy and submission support
- Represent HTA & DS in EU Joint Clinical Assessment (EU JCA) dossier teams, shaping and contributing to delivering PICO strategy and informing dossier development strategy. Ensure cross-program consistency and sharing of key lessons learned.
- Clinical Trial Design/ Protocol Reviews
- Provide Market Access technical and scientific review at Protocol Review Committee to ensure patient‑ and payer‑relevant study designs.
- Capability development
- Contribute to and deliver HTA capability development, internal briefings, external positioning documents, and external thought leadership.
- Serve as an HTA & DS expert for product teams, providing strategic guidance on HTA agency/ payer requirements, and drive organizational learning.
Qualifications and Experience
- Advanced degree (MSc, PhD, PharmD, MD, or equivalent) in a relevant discipline (eg., Epidemiology, Biostatistics, (health) Economics, HTA, Medicine, Public Health).
- At least 7 years of experience in HTA, market access, evidence generation, or related fields, in a pharmaceutical organization and/or external agency.
- Strong R&D acumen
- Experience working across multiple therapeutic areas (ideally including one or more of Oncology, Immunology, Neuroscience, Cardiopulmonary) and phase 2, 3 development and launch phases.
- Strong understanding of international health care, HTA, payer and regulatory environments, with one or more of Europe, the US, and Japan preferred.
Capabilities and Leadership Attributes
- Global mindset with proven ability to lead, influence, and collaborate across diverse global, cross‑functional teams.
- Strong strategy development capabilities with the ability to understand, synthesize and translate complex evidence into scenario planning and actionable directions.
- Advanced analytical and critical thinking skills.
- Intellectual curiosity and creativity to challenge existing approaches and develop innovative solutions.
- Clear, confident communicator (verbal and written).
- Ability to plan, prioritize, and deliver work effectively in a highly matrixed environment with competing demands.
- Demonstrated commitment to continuous learning and capability development.
Required Skills:
Preferred Skills:
Agility Jumps, Commercial Awareness, Competitive Landscape Analysis, Cross-Functional Collaboration, Customer Intelligence, Global Market, Go-to-Market Strategies, Health Economics, Health Intelligence, Market Knowledge, Market Opportunity Assessment, Mentorship, Pricing Strategies, Regulatory Compliance, Strategic Change, Tactical Planning, Technical Credibility
The anticipated pay range for this position, in the primary posting location, is:
€127.500,00 - €219.305,00The anticipated pay ranges for additional locations are:
US - The anticipated base pay range for this position is $164,000.00 - $282,900.00
Benefits:
In addition to base pay, we offer the following benefits*: an annual bonus with set target (% of pay) depending on pay grade / location, where the actual amount is based on the employees’ and companies’ performance of the previous calendar year, or sales commissions. Moreover, we offer vacation days, parental leave for a minimum of 12 weeks, bereavement leave, caregiver leave, volunteer leave, well-being reimbursement, programs for financial, physical and mental health. We also offer service anniversary and recognition awards, and subject to the terms of their respective plans, employees - and in some location’s eligible dependents - can participate in several insurance plans. For more information, visit Employee benefits | Supporting well-being & career growth | Johnson & Johnson Careers.
*This is for informative purposes only. Amounts and actual benefits may vary by location and are subject to change.
Skills Required
- Advanced degree in relevant discipline (Epidemiology, Biostatistics, Health Economics, Medicine, Public Health)
- At least 7 years of experience in HTA, market access, or evidence generation in pharmaceutical organizations
- Strong understanding of international healthcare, HTA, payer and regulatory environments
Johnson & Johnson Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Johnson & Johnson and has not been reviewed or approved by Johnson & Johnson.
-
Healthcare Strength — Healthcare coverage is characterized as comprehensive across medical, dental, and vision, with added supports like onsite clinics, fitness centers, and Employee Assistance resources. Mental-health services and wellbeing reimbursements are also described as meaningful components of the overall package.
-
Retirement Support — Retirement offerings are portrayed as a major differentiator, combining a 401(k) with employer matching and an employer-funded pension plan. Stock options and other long-term financial supports are also positioned as part of the broader rewards mix.
-
Parental & Family Support — Family-related benefits are presented as notably strong, including paid parental leave for all new parents and additional leave types for caregiving and bereavement. Financial assistance for adoption, fertility treatment, and surrogacy is highlighted as a significant support.
Johnson & Johnson Insights
What We Do
Profound Change Requires Boldness. Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the health of their skin. Those working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. Imagine what the rest of our team of 134,000 people at 260 companies in more than 60 countries across the world is accomplishing. We redefine what it means to be a big company in today’s world. Social Media Community Guidelines: http://www.jnj.com/social-media-community-guidelines
